Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hemangioma 3Prostatic Neoplasms 2Uterine Cervical Neoplasms 1Melanoma 1Hemangioma, Cavernous, Central Nervous System 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 5Ketamine 3Standard of Care 2Methods 2Early Intervention, Educational 2Yoga 1Ultraviolet Therapy 1Self-Help Groups 1Psychotherapy, Group 1Psychotherapy 1Psychiatric Rehabilitation 1Propranolol 1Practice Guidelines as Topic 1N-Methyl-3,4-methylenedioxyamphetamine 1Mindfulness-Based Stress Reduction 1Midazolam 1Melatonin 1Meditation 1Interviews as Topic 1Exercise Therapy 1Educational Status 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Anxiety Disorders × Propranolol × Clear all
NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡